`

BioPhy

Biotechnology Research

Specialities :
Ai
Innovation
Healthcare
Clinical trials
Ai drug development

+4

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$4.5M
size-icon Size
11 - 50

Frequently Asked Questions About BioPhy

What does Biophy do?+

Leveraging the possibilities of modern science and advanced technologies, BioPhy is committed to transforming the way promising drugs are identified, developed, and tested. With the help of our patent-pending predictive AI engine BioLogic, and our generative AI solution BioPhyRx, we work to enhance the outcomes of clinical trials, reduce failure and non-compliance rates, accelerate the pace of developing new drugs, and moreover, improve the quality of healthcare outcomes across the globe. Meet the founders: Dave Latshaw II, Ph.D.: https://www.linkedin.com/in/davidlatshawii/ Steve Truong: https://www.linkedin.com/in/stevenhtruong1 Daniel Sciubba, MD: https://www.linkedin.com/in/daniel-sciubba-md-wharton-mba-cand BioPhy is a Philadelphia-based, venture backed company. Contact us at info@biophy.ai

What are Biophy's specialties? +

Ai,innovation,healthcare,clinical trials,ai drug development,generative ai,regulatory intelligence,quality intelligence,and search and evaluation

What is Biophy's industry? +

Biophy operates in the Biotechnology research industry.

What is Biophy's revenue? +

Biophy's revenue is 11m - 100m

What is Biophy's company size? +

Biophy has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.